Zinzino AB (publ) delivered solid growth in September 2026. Revenue in Zinzino’s sales markets increased by 15% and reached SEK 310.9 million, compared with SEK 270.8 million in the same month last year.
Faun Pharma’s external sales also rose sharply to SEK 6.4 million from SEK 3.7 million. As a result, total Group revenue grew 16% to SEK 317.3 million, up from SEK 274.5 million a year earlier.
In the third quarter of 2026, revenue in Zinzino’s sales markets rose 18% to SEK 917.3 million (SEK 774.8 million). Total Group revenue increased by the same rate of 18% and amounted to SEK 928.2 million (SEK 784.1 million).
Accumulated revenue for the first nine months of 2026 (January–September) grew 21% to SEK 2,787.1 million, compared with SEK 2,302.2 million in the same period of 2025.
Regional Revenue Breakdown
Regions | Sep 2026 | Sep 2025 | Change | Q3 2026 | Q3 2025 | Change | YTD 2026 | YTD 2025 | Change |
The Nordics | 26.6 | 25.5 | 5% | 76.1 | 78.7 | -3% | 233.8 | 234.1 | 0% |
Central Europe | 102.9 | 93.4 | 10% | 288.8 | 242.4 | 19% | 846.5 | 657.5 | 29% |
East Europe | 25.5 | 29.3 | -13% | 76.7 | 89.6 | -14% | 243.0 | 276.0 | -12% |
South & West Europe | 48.9 | 48.9 | 0% | 144.1 | 136.0 | 6% | 451.4 | 398.0 | 13% |
The Baltics | 8.2 | 8.8 | -7% | 24.8 | 28.5 | -13% | 81.3 | 85.2 | -5% |
North America | 62.2 | 39.8 | 56% | 195.0 | 126.1 | 55% | 596.4 | 373.7 | 60% |
South America | 3.6 | 1.3 | 177% | 10.1 | 3.5 | 189% | 32.8 | 8.2 | 300% |
Asia-Pacific | 30.9 | 22.0 | 40% | 95.1 | 64.2 | 48% | 237.2 | 213.2 | 11% |
Africa | 2.1 | 1.9 | 11% | 6.5 | 5.8 | 12% | 18.8 | 16.0 | 18% |
Zinzino | 310.9 | 270.8 | 15% | 917.3 | 774.8 | 18% | 2,741.2 | 2,261.9 | 21% |
Faun Pharma | 6.4 | 3.7 | 73% | 10.9 | 9.3 | 17% | 45.9 | 40.3 | 14% |
Zinzino Group | 317.3 | 274.5 | 16% | 928.2 | 784.1 | 18% | 2,787.1 | 2,302.2 | 21% |
North America and South America delivered the strongest growth rates. North America rose 56% in September and 60% year-to-date. South America posted exceptional gains of 177% in September and 300% for the first nine months.
Central Europe and Asia-Pacific also showed healthy increases. East Europe and the Baltics recorded declines during the period.
Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company based in Scandinavia. The company specializes in test-based, personalized nutrition and scientific skincare. Its shares are listed on Nasdaq First North Premier Growth Market.
Zinzino’s scientifically proven nutritional supplements are available in more than 100 markets worldwide. The company has acquired assets from several health and wellness businesses, including It Works!, Enhanzz Global, Truvy, Bodē Pro, Valentus, Zurvita, Xelliss, and Sanki Global.
Zinzino co-owns the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD. It also owns the Swiss biotech skincare brand HANZZ+HEIDII as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS.
The company is headquartered in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia. For more information, visit zinzino.com.
There are no reviews yet. Be the first one to write one.
